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Abstract
Background: The aim of the study was to develop a menopause-specific, preference-based health-
related quality-of-life (HRQoL) index reflecting both menopausal symptoms and potential side-
effects of Hormone Replacement Therapy (HRT).
Methods: The study had three phases: the development of a health state classification, a
prospective valuation survey and the estimation of a model to interpolate HRQoL indices for all
remaining health states as defined by the classification. A menopausal health state classification was
developed with seven dimensions: hot flushes, aching joints/muscles, anxious/frightened feelings,
breast tenderness, bleeding, vaginal dryness and undesirable androgenic signs. Each dimension
contains between three and five levels and defines a total of 6,075 health states. A sample of 96
health states was selected for the valuation survey. These states were valued by a sample of 229
women aged 45 to 60, randomly selected from 6 general practice lists in Sheffield, UK. Respondents
were asked to complete a time trade-off (TTO) task for nine health states, resulting in an average
of 16.5 values for each health state.
Results: Mean health states valued range from 0.48 to 0.98 (where 1.0 is full health and zero is for
states regarded as equivalent to death). Symptoms, as described by the classification system, can be
rank-ordered in terms of their impact (from high to low) on menopausal HRQoL as follows: aching
joints and muscles, bleeding, breast tenderness, anxious or frightened feelings, vaginal dryness,
androgenic signs. Hot flushes did not significantly contribute to model fit. The preferred model
produced a mean absolute error of 0.053, but suffered from bias at both ends of the scale.
Conclusion: This article presents an attempt to directly value a condition specific health state
classification. The overall fit was disappointing, but the results demonstrate that menopausal
symptoms are perceived by patients to have a significant impact on utility. The overall effect is
modest compared to the more generic health state descriptions such as the EQ-5D. The resultant
algorithm generates a preference-based index that can be used economic evaluation and that
reflects the impact of this condition.
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The increasing demand for economic evaluation of health
care interventions has lead to a corresponding rise in the
derived demand for evidence on the key parameter inputs
into cost effectiveness models. One of those inputs is the
health state utility value used to estimate the quality
adjusted life years (QALYs) associated with an interven-
tion. This article is concerned with estimating a prefer-
ence-based measure for generating utility values for
menopausal health states.
Most preference-based measures of health such as the EQ-
5D, SF-6D and the Health Utilities Index 3, have a generic
health state descriptive system [1-3]. However, general
measures of health have been found to be inappropriate
or insensitive for some medical conditions [4], and it has
been found that these instruments are not sufficiently sen-
sitive to the impact of menopausal symptoms [5,6]. There
has been increasing interest in estimating preference-
based indices from condition specific measures. These
have often involved mapping from condition specific
measures onto preference-based measures [4,7-9]. While
this approach is useful, it is a second best solution for
studies that did not use a generic measure and the aim is
to estimate generic preference scores. However, for some
conditions generic measures may not be appropriate and
in this case a better solution would be to elicit preference
weights for the condition specific measure [10]. There
have been a number of studies published recently that
have estimated conditions specific preference scores,
including for Rhinitis [11], Erectile Dysfunction [12],
asthma [13] and Prostate symptoms [14]. This is the first
attempt to estimate a preference-based measure for men-
opausal symptoms.
The aim of this study is to quantify the impact of meno-
pause-related health problems on health-related quality
of life as indicated by a "strength-of-preference" index.
This project had three components. The first was to con-
struct a health state classification system for menopausal
symptoms based on work by Zoellner and others [15];
secondly a sample of menopausal health states defined by
the latter were then valued by means of the time trade-off;
and then modelled the health state values using regression
techniques to produce an algorithm for valuing all states
described by the menopausal health state system.
Methods
The menopause-specific health state classification
A menopause-specific quality-of-life questionnaire has
been developed by Zoellner and colleagues [6,15]. Ini-
tially, a pool of 39 menopause-related items – identified
as being important on the grounds of two focus group ses-
sions of peri- and postmenopausal women, literature
review, and expert opinion – underwent intensive analysis
to determine the degree of fulfilment of standard psycho-
metric criteria of re-test reliability, face validity, construct
validity and convergent validity.
The application of these criteria resulted in a question-
naire with 22 items grouped into 6 domains, namely (1)
psychosocial, (2) physical, (3) vasomotor, (4) sexual, (5)
menstrual, and (6) androgenic complaints. In order to
derive a health state classification from the former, the
Table 1: The Menopause health state classification
1. hot flushes
1) You have no hot flushes
2) You get 1–3 hot flushes per day
3) You get 4 or more hot flushes per day
2. aching joints or muscles
1) You have no aching joints or muscles at all.
2) You have 1–3 episodes of aching joints or muscles per week.
3) You have 4 or more episodes of aching joints or muscles per week.
4) You have mild to moderate constant pain in your joints or muscles.
5) You have severe constant pain in your joints or muscles.
3. anxious or frightened feelings
1) You do not have anxious or frightened feelings.
2) You have anxious or frightened feelings 1–3 times per week.
3) You have anxious or frightened feelings 4 or more times per week.
4. breast tenderness
1) You have no breast tenderness.
2) You have mild to moderate breast tenderness.
3) You have severe breast tenderness
5. bleeding
1) You have no bleeding
2) You have mild regular (monthly) bleeding
3) You have mild irregular bleeding
4) You have intense regular (monthly) bleeding
5) You have intense irregular bleeding
6. undesirable cosmetic signs (facial or body hair growth, 
greasy skin or acne)
1) You have no undesirable cosmetic signs.
2) You have mild to moderate undesirable cosmetic signs
3) You have severe undesirable cosmetic signs.
7. vaginal dryness
1) You have no vaginal dryness.
2) You have mild to moderate vaginal dryness.
3) You have severe vaginal dryness.Page 2 of 9
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was felt important to cover potential side-effects of Hor-
mone Replacement Therapy (HRT), the menstrual
domain is represented with two items – 'breast tenderness'
and 'vaginal bleeding' – in the classification systems; the
latter hence consists of the following seven domains of
menopausal health (see table 1): hot flushes, aching
joints/muscles, anxious/frightened feelings, breast tender-
ness, bleeding, vaginal dryness and undesirable andro-
genic signs. The assignment of the number as well as the
descriptor of levels was performed according to the fre-
quency distributions observed in the screening section of
the postal survey (n = 785, Table 1). Each dimension con-
tains between three and five levels and defines a total of
6,075 health states.
The valuation survey
The design of the survey was to elicit values for a sample
of states defined by the menopausal health state classifica-
tion using a variant of the Time Trade-off (TTO) on a sam-
ple of women aged 45 to 60. The key design issues were
the sample of health states to be valued, the sample of
respondents, the valuation technique and the interview.
Selection of health states
It is not possible to value all the states defined by the men-
opausal specific health state classification. However, there
is currently little guidance of the selection of states for val-
uation [16]. Based on past practice, the states used in this
survey were selected using the orthoplan programme in
SPSS. This programme generates an orthogonal array of
states that need to be valued in order to estimate an addi-
tive model. This programme indicated that 49 states were
necessary to estimate an additive model. It was decided to
enhance these states in order to ensure some degrees of
freedom and to permit some examination of interactions.
Therefore, the programme selected another 47 as 'hold
out' states drawn at random. This resulted in a total of 96
health states valued out of a potential of 6,075 defined by
the menopausal health state classification system.
Each respondent was asked to value a sample of eight
states. These states were selected from the larger sample of
96 using a stratified sampling technique to ensure that
each respondent has a mix of mild, moderate and more
severe states. The severity of the states has been assessed
by summing the dimension levels. The states were then
ranked using this sum score and divided into quartiles to
identify four severity groups. Two health states have been
selected at random without replacement from each sever-
ity group to form a set of eight health states. This was done
another 11 times to create 12 sets of states. These 12 sets
were used an equal number of times in order to ensure
that each of the 96 states would be valued an equal
number of times.
The original aim was to interview 150 respondents, where
each respondent valued eight health states. This would
mean undertaking 24 sessions with between 6–8 respond-
ents at each session and would have resulted in 1200
observations and an average of 12.5 valuations per state.
Selection of respondents
A previous survey was undertaken in Sheffield (UK) with
the main aim of validating the new questionnaire
designed to assess the health of women in mid -life. One
thousand and eighty women aged 45 to 60 were randomly
selected from the lists of 6 GPs in Sheffield (180 women
per GP List) and sent the postal questionnaire concerning
their menopausal symptoms. Of these 790 (73%) were
returned. Five were dropped from further analysis due to
incomplete response, so the total number was 785
responders. All responders were sent a summary of the
study "Women's Health in Mid life" in December 2001
and asked if they would be interested in participating in a
second phase of the study. Out of these 417 women
replied saying they would like more information of the
phase 2 study.
The 6 GP practices signed a consent form agreeing to these
women being invited to participate in the valuation sur-
vey. Invitation letters were sent by each practice with a
Patient information sheet and a Patient consent form. Out
of the 417, 229 (55%) attended the interviews and com-
pleted a questionnaire.
Valuation technique
Health states were valued using a variant of the time trade-
off technique (TTO). This technique asks the respondent
to choose between a fixed period of time (t) in the health
state to be valued compared to a shorter period in full
health (x). The amount of time spent in full health is var-
ied until the respondent is indifferent between the two
alternatives. The value of the health state is then x/t for
states better than dead.
This study used a self-completed variant of TTO devel-
oped by Gudex that uses a titration procedure shown in
Table 2, where the respondent is presented with two lists
of values [17]. Each row has a value of 25 for t and a
declining value for x, where the value of x declines by one
year between each row. Twenty-five years was chosen to
represent a reasonable life expectancy for this sample of
respondents. The respondent is asked to indicate all the
cases where they are confident they would choose A (i.e.
the health state to be valued), all the cases where they
would choose B (i.e. full health) and the put an equals
against states where they cannot choose. There was no
allowance for states worse than death, but this was felt to
be an unlikely scenario for states defined by the menopau-
sal health state classification.Page 3 of 9
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Respondents were invited to attend interview sessions
held in a room at the Institute of General Practice in Shef-
field (UK). Two researchers experienced in interviewing
patients coordinated these sessions. The interview began
with the researchers explaining the purpose of the survey
and to explain the TTO task. Patients were asked to com-
plete an example and encouraged to ask questions in
order to aid in their understanding. Once the respondents
were ready, they were then asked to complete all remain-
ing questions on their own. There were 33 such interview
sessions in the survey. Respondents were reimbursed for
their time and travel with a voucher for £10.
The questionnaire had questions on age, occupation, edu-
cation level, general health, whether or not they had
stopped menstruating and if so when, and finally whether
or not they continued to take HRT. They were then asked
to complete the menopausal health state classification.
They then undertook a practice TTO question followed by
eight TTO questions. The health states were presented in a
random order to avoid the risk of an ordering effect.
Finally they were asked to value their own health using a
TTO question.
Modelling
The overall aim is to construct a model for predicting
health state valuations based on the menopausal health
state classification. The data generated by the valuation
survey described above has a complex structure, as they
are skewed and health state valuations are clustered by
respondent. Disentangling the respondent effect is a com-
plex task and can only be tackled at the individual level,
where each valuation is regarded as a separate observa-
tion, rather than using the mean value for each health
state. The former has the advantage of greatly increasing
the number of degrees of freedom available for the analy-
sis (from 96 to over 1200) and enabling the analysis of
respondent background characteristics on health state
valuations.
A number of alternative models have been proposed for
estimating preference functions from health data
[12,14,15]. The general model has been defined else-
where as [12]:
yij = g (β'xij + θ'rij + δ'zj) + εij  (1)
where i = 1, 2, ..., n represents individual health state val-
ues and j = 1,2, ..., m represents respondents. The depend-
ent variable, yij, is the TTO score for health state i valued
by respondent j. x is a vector of binary dummy variables
(xδλ) for each level λ of dimension δ of the classification.
Level λ = 1 acts as a baseline for each dimension, so in a
simple linear model, the intercept represents state
1111111, and summing the coefficients of the 'on' dum-
mies derives the value of all other states.
The r term is a vector of terms to account for interactions
between the levels of different attributes. z is a vector of
personal characteristics that may also affect the value an
individual gives to a health state, for example, age, sex and
education. The role of personal characteristics is not dis-
cussed in this paper. g is a function specifying the appro-
priate functional form. εij is an error term whose
autocorrelation structure and distributional properties
depend on the assumptions underlying the particular
model used.
This is an additive model, which imposes no further
restrictions on the relationship between dimension levels
of the classification. For example, it does not enforce an
interval scale between the levels of each dimension and
does not impose ordinality on the levels.
Table 2: The time trade-off question
Choice A ---- Choice B
25 years 25 years
25 years 24 years
25 years 23 years
25 years 22 years
25 years 21 years
25 years 20 years
25 years 19 years
25 years 18 years
25 years 17 years
25 years 16 years
25 years 15 years
25 years 14 years
25 years 13 years
25 years 12 years
25 years 11 years
25 years 10 years
25 years 9 years
25 years 8 years
25 years 7 years
25 years 6 years
25 years 5 years
25 years 4 years
25 years 3 years
25 years 2 years
25 years 1 year
25 years 0 years
Please put an "A" against all cases where you are CONFIDENT that 
you would choose Choice A.
Please put a "B" against all cases where you are CONFIDENT that 
you would choose Choice B.
Please put an "=" against the case where you cannot choose 
between Choice A and Choice B.Page 4 of 9
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error structure, with independent error terms, that is
cov(εijεi'j) = 0, i≠i'. This specification ignores the clustering
in the data and assumes that each individual health state
value is an independent observation, regardless of
whether or not it was valued by the same respondent. An
improved specification, which takes account of variation
both within and between respondents, is the one-way
error components random effects model. This model
explicitly recognises that n observations on m individuals
is not the same as n × m observations on different individ-
uals. Estimation is via generalised least squares (GLS) or
maximum likelihood (MLE).
Analysis of first order interactions alone is problematic,
since the large number of possible interactions means
there is a risk of finding some are significant purely by
chance. We have therefore adopted the approach used in
other studies of using summary terms for describing inter-
actions [16,18]. Extreme level dummies were created to
represent the number of times a health state contains
dimensions at the extreme ends of the scale [18]. Least
severe is defined as level 1 on each dimension. Most
severe is defined as the bottom level of each dimension.
These are used to create dummy variables LEAST and
MOST which take a value of 1 if any dimension in the
health state is at the least (most) severe level, and 0
otherwise.
Finally we consider alternative functional forms – g in (1)
– to account for the skewed distribution of health state
valuations. Four functional forms are used. Firstly, a Logit
transformation and two complementary log-log transfor-
mations suggested by Abdalla and Russell. [19] These are
chosen to map the data from the range (-1,1) to the range
(-∞,∞) via the unit range (0,1). Secondly, a Tobit transfor-
mation which, although designed to deal with truncated
data, can approximate for the left skew in this data, where
25% of the values lie between 0.9 and 1. Specifying a
Tobit model with upper censoring at 1 does this.
All modelling will be done using STATA 7.0 and SPSSWin.
Results
Respondents
The characteristics of the 229 interviewed women are pre-
sented on Table 3. Their mean age was 54 with a range
between 46 and 61. Seventy four percent had stopped
menstruating and the average time to since they last men-
struated was 64 months. A third had taken HRT in the last
month. The respondents reported their general health to
be in the mid-range of the excellent to poor scale. The
seven menopausal symptoms were highly prevalent, with
two thirds experiencing aching joints and muscles, nearly
half reporting hot flushes and vaginal dryness and around
one third experiencing anxiety or fright, breast tenderness
and cosmetic signs. The mean valuation of their current
health state by the TTO was 22.8 (SD = 4.4) which trans-
lated into a health state utility value of 0.91.
Thirty respondents were excluded from the modelling
data set, leaving 199. Respondents were excluded due to
ambiguity in the responses to the (self-administered)
questionnaire. The main sources of ambiguity were the
mixing up of responses (e.g. ticks and crosses appearing
the wrong way around) and large gaps between the
responses with no indication of the appropriate point of
indifference. There were also a number of individual
responses elicited from 199 respondents that had to be
excluded due to similar ambiguities. These exclusions left
1580 health state values across the 96 health states for
modelling, a final completion rate of 86% of all questions
asked at interview.
Health state values
Descriptive statistics for 50 of the 96 states are presented
on Table 4. Each health state is valued on average 16.5
times, which exceeds the original target. Mean health state
values range from 0.48 to 0.98 with large standard devia-
tions. The median values usually exceed the mean values,
reflecting the highly skewed nature of the data. This
skewness is even more apparent at the individual level, as
Table 3: Characteristics of respondents
Full sample n = 229
Age: mean (s.d) 53 (SD)
Highest qualification %
Degree 26
A levels 11
Other 63
Self-rated general health: %
Excellent 7
Very good 44
Good 31
Fair 14
Poor 4
Reporting the following: %
Hot flushes 45
Aching joints or muscles 74
Anxious or frightened 37
Breast tenderness 31
Bleeding 23
Cosmetic signs 35
Vaginal dryness 45
TTO own valuation 22.8 (4.4)
Stopped menstration 74
Average time since stopped 
menstruation (months)
64 (72)
Taken HRT in last month 35Page 5 of 9
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State Mean n s.d. Median maximum Minimum
1112311 0.93 16 0.08 0.98 0.98 0.78
1112422 0.87 16 0.16 0.90 1.00 0.38
1112433 0.79 15 0.24 0.94 0.98 0.26
1113122 0.88 18 0.16 0.94 0.98 0.42
1113232 0.79 17 0.23 0.82 1.00 0.02
1113512 0.82 15 0.21 0.94 0.98 0.38
1113531 0.80 17 0.22 0.90 0.98 0.38
1121223 0.83 18 0.16 0.88 0.98 0.42
1121331 0.86 16 0.17 0.90 1.00 0.42
1211522 0.87 15 0.19 0.98 1.00 0.38
1322231 0.71 18 0.31 0.84 0.98 0.00
1323123 0.81 14 0.22 0.90 0.98 0.22
1323231 0.72 18 0.27 0.84 0.98 0.22
1331412 0.80 15 0.23 0.90 0.98 0.22
1331432 0.56 13 0.22 0.54 0.94 0.06
1332213 0.77 18 0.23 0.88 0.98 0.26
1333112 0.84 18 0.19 0.92 0.98 0.42
1413211 0.68 13 0.22 0.74 0.90 0.10
1413513 0.78 15 0.22 0.82 0.98 0.22
1423133 0.76 18 0.21 0.80 0.98 0.26
2221511 0.67 13 0.25 0.74 0.98 0.06
2223131 0.83 17 0.14 0.82 1.00 0.54
2231312 0.89 15 0.13 0.98 1.00 0.54
2233333 0.48 13 0.28 0.42 0.98 0.06
2311511 0.87 18 0.16 0.92 1.00 0.42
2313123 0.96 16 0.04 0.98 1.00 0.86
2321122 0.70 13 0.24 0.74 0.98 0.10
2332413 0.54 13 0.26 0.54 0.98 0.06
2421212 0.92 17 0.09 0.98 1.00 0.70
2421322 0.82 18 0.19 0.92 0.98 0.42
2521323 0.65 18 0.30 0.78 0.94 0.00
2523423 0.71 16 0.23 0.74 0.98 0.34
2532323 0.83 18 0.24 0.88 0.98 0.00
2532531 0.71 16 0.26 0.72 0.98 0.14
2533311 0.77 15 0.31 0.94 1.00 0.04
3121111 0.92 17 0.15 0.98 1.00 0.42
3121533 0.81 18 0.20 0.86 0.98 0.34
3132211 0.83 16 0.19 0.90 1.00 0.34
3133412 0.79 17 0.21 0.90 0.98 0.34
3133521 0.67 15 0.26 0.78 0.98 0.14
3232433 0.77 15 0.27 0.90 0.98 0.18
3311433 0.75 17 0.24 0.82 0.98 0.42
3312321 0.89 16 0.14 0.94 0.98 0.46
3412222 0.80 18 0.19 0.86 0.98 0.42
3413111 0.83 18 0.29 0.94 0.98 0.06
3422113 0.82 16 0.14 0.82 0.98 0.56
3422412 0.78 15 0.29 0.90 1.00 0.06
3431133 0.80 16 0.19 0.86 0.98 0.38
3433532 0.71 18 0.32 0.80 0.98 0.02
3511211 0.80 17 0.23 0.86 0.98 0.38
Please put an "A" against all cases where you are CONFIDENT that you would choose Choice A. Please put a "B" against all cases where you are 
CONFIDENT that you would choose Choice B. Please put an "=" against the case where you cannot choosebetween Choice A and Choice 
B.Page 6 of 9
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health states values were 1.0 (32/1580) indicating that
that most respondents were willing to trade time for qual-
ity of life, however 31% were at the next possible value of
24.5 years. At the other end of the scale, only three had a
value of zero where it might have been possible that
respondents regarded these states as worse than death.
Modelling
Basic models: main effects
The Breusch-Pagan test for individual effects suggests
these are important (χ2 = 25585.15, P = 0.000) and Haus-
man's test suggests random rather than fixed effects is the
appropriate specification (χ2 = 27.11, P = .035), therefore
only Random Effects (RE) and mean models are presented
in Table 5. The main effects dummies in each model rep-
resent levels of each dimension of the menopausal health
state classification. These are expected to have a negative
sign and to increase in absolute value within each dimen-
sion. It would be inconsistent with the scale for the abso-
lute value to decrease when moving to a worst level within
a dimension.
In the RE model (1), the coefficients have the expected
negative sign for all main effect dummies except HF2 and
VAG2, but neither of these is significant. There are 13 sig-
nificant coefficients, including the constant term. There
are three inconsistencies involving significant coefficients,
AJ3 to AJ4, BL2 to BL3 and BL4 to BL5. The mean model
has a better explanatory power than the OLS model (not
shown), but has only seven significant coefficients that
produce just two inconsistencies.
The ability of the mean and RE main effects models to pre-
dict health state valuations within the data set is presented
at the bottom of Table 5. The main effects models have
similar mean absolute errors, though it is slightly lower
for the mean model. The proportion of errors greater than
0.05 and 0.1 is also very similar at 39% and 15% respec-
tively. The JB test found evidence for non-normality of
errors for both the models.
An important problem has been identified by the Ljung-
Box statistics that reveal significant autocorrelation in the
prediction of all the models. Plots of actual against pre-
dicted errors reflect a tendency to over predict at the lower
end and under predict at the upper end. The model was re-
estimated using a Tobit procedure, but this did not
Histogram for TTO valuesFigure 1
Histogram for TTO values.
TTO values
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Table 5: Models
Main effects only Interaction effects
(1) (2) (3) (4)
RE Mean RE Mean
c 0.912 0.917 0.925 0.879
HF2 0.007 -0.008 0.006 -0.005
HF3 -0.006 0.008 -0.002 0.013
AJ2 -0.016 -0.013 -0.016 -0.0106
AJ3 -0.026 -0.062 -0.024 -0.062
AJ4 -0.023 -0.022 -0.022 -0.021
AJ5 -0.070 -0.085 -0.066 -0.08
EM2 -0.012 -0.018 -0.012 -0.018
EM3 -0.034 -0.057 -0.029 -0.051
BT2 -0.018 -0.002 -0.018 0.000
BT3 -0.033 -0.039 -0.028 -0.032
BL2 -0.041 -0.026 -0.039 -0.024
BL3 -0.057 -0.025 -0.057 -0.022
BL4 -0.066 -0.058 -0.068 -0.054
BL5 -0.062 -0.043 -0.059 -0.037
COS2 -0.004 0.010 -0.003 0.014
COS3 -0.015 -0.028 -0.011 -0.024
VAG2 0.006 -0.008 0.006 -0.006
VAG3 -0.024 -0.035 -0.02 -0.029
MOST -0.026 -0.013
LEAST 0.002 0.035
N 1580 96 1580 96
adj R2 0.040 0.178 0.039 0.164
inconsistencies 3 2 2 3
MAE 0.056 0.053 0.065 0.0552
No > |0.05| 37 36 47 36
No > |0.10| 14 15 17 15
t(mean = 0) -0.334 † -0.344 †
JBPRED 34.789 20.587 36.089 17.028
LB 214.99 124.92 218.04 150.44
Estimates shown in bold are significant at t0.10; † Mean error is zero 
by definition.Page 7 of 9
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Applications of the logit and complementary log func-
tions also did not improve model performance.
Interactions
The RE and mean models in Table 5 include dummy var-
iables for MOST and LEAST, which take the value of 1 if
any dimension is at the most or least severe level respec-
tively. The coefficients associated with these dummies
suggest a further negative impact when any dimension is
at its worst level and a slight positive impact from having
any dimension at the least severe level. These coefficients
were significant for some models. However, the coeffi-
cients on the main effects have been slightly reduced by
these additional dummies, particularly the worst levels of
AJ5 and BL5. Furthermore, the addition of these variables
has not significantly improved either model
Discussion
The paper presents the results of a study aiming to esti-
mate preference functions for the menopausal health state
classification. The preference models look credible in
terms of the coefficients, though there are a number of
problems with the models predictive performance. This
paper supports the findings of other studies, that it is the
feasible to estimate condition specific preference-based
indices [11-14].
It was perhaps more ambitious than other published stud-
ies in that it attempted to estimate values for a large health
state classification, where it was not possible to directly
value all states. It was the first study using statistical infer-
ence to model health state values. The explanatory power
of the models is not high. This is due to the high
variability around the health state means, which may have
been a result of the self-completed format of the TTO task.
It may also have been due to comparatively low number
of observations per state.
The classification describes health states that are mild
compared to the full range of states described by descrip-
tive systems such as the EQ-5D or HUI3 that reflects the
nature of the conditions. The specific values found for our
instrument have tended to be more skewed at the upper
end than the generic measures, such as the EQ-5D. This
was also found for a number of other conditions, with the
lowest value for Erectile Dysfunction being 0.74 [12] and
0.87 for prostate symptoms [14]. However this seems to
be a consequence of the comparatively mild impact of this
condition, because a preference scale for Asthma had a
lowest value of 0.04 [13] and 0.15 for Rhinitis [11]. For
milder conditions a valuation technique such as TTO that
relies on trading quality with survival may be rather insen-
sitive for some respondents, which is reflected in the
higher proportion of people indicting the first response
choice down the scale. This might suggest that more effort
needs to be made to develop variants of the TTO and SG
that allow milder states to be valued with sufficient sensi-
tivity. One approach would be the use of chaining, where
each mild state is valued against full health and a lower
anchor that is better than being dead, which in turn has
been valued against full health [20]. However, this has
been shown to produce biased estimates [21,22].
A further problem may have arisen from the descriptive
system. The 2 or 3 inconsistencies between coefficients
may be due to possible ambiguities in the health state
classification. The ranking of AJ3 and AJ4 is ambiguous,
since it is possible for 4 or more episodes per week of pain
to be worse than mild to moderate constant pain. Also for
BL, some people may regard irregular bleeding as better
than regular bleeding. Such differences of opinion in the
population in the ranking ordering of some levels would
reduce the fit of the models.
Of more concern is the evidence for systematic patterns in
the residuals resulting in over prediction at the lower end
and under predicting at the upper end of the range. The
MVH group was able to solve this problem in their valua-
tion of the EQ-5D by the inclusion of an interaction term.
The inclusion of interaction terms in this study had little
impact on the problem. The application of various trans-
formations to the dependent variable also did not solve
this problem.
The models nonetheless provide a basis for valuing men-
opausal health states using this health state classification.
The coefficients are consistent with the cordiality of the
health state classification and the size of the mean abso-
lute error of 0.055 to 0.065 is comparable to that achieved
in other models [16]. The addition of interaction terms
did not improve the model and tended to offset the main
effects, therefore it is not proposed to recommend the
models with interactions. The choice of models is
between the random effects and mean main effects mod-
els (i.e. (1) and (2)). Given the mean model is slightly bet-
ter in terms of fit and numbers of inconsistencies this is
the one recommended for use.
The estimation of preference weights for condition spe-
cific quality of life has been questioned by some health
economists as to its value [23]. The argument for using
condition specific descriptive systems is that they are
likely to be more sensitive to changes in the condition
than generic measures and more relevant to the concerns
of patients. On the other hand, condition specific
measures often focus on symptoms and it could be argued
this concentrates the mind of the respondent on the
negative aspects of the conditions. This may have a fram-
ing effect that produces lower values because the respond-Page 8 of 9
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unaffected by the condition. However, the risk of this was
reduced by selecting women in the age range of 45–60,
most of whom had experienced menopausal symptoms
and would have a realistic view of the likely impact of the
condition.
The argument for using condition specific descriptive sys-
tems is that they are going to better reflect the impact of
the condition on a patient's life. However, provided the
descriptive system is valued on the same full health –
death scale using the same variant of the same valuation
technique using a comparable population sample, then
the valuations should be comparable. Any remaining dif-
ferences in values should be a legitimate consequence of
the descriptive system. However, this assumes that the
value of a dimension is independent of those dimensions
outside of the descriptive system and this requires empir-
ical testing. Despite these arguments, there has been
increasing interest in estimating condition specific prefer-
ence measures of health because the analyst often only
has condition specific data and wishes to use them to
undertake an economic evaluation, or the analyst feels a
generic measure is not appropriate for the condition.
Conclusion
The advantages of using a condition specific descriptive
system over a generic are that it should be more sensitive
to improvements in health. However, the overall fit was
disappointing. The results demonstrate that menopausal
symptoms are perceived by patients to have a significant
impact on utility, but the overall effect is modest com-
pared to the more generic health state descriptions such as
the EQ-5D. This research has also demonstrated the
problems that can be encountered when trying to value a
comparatively mild condition. The resultant algorithm
generates a preference-based index that can be used eco-
nomic evaluation and that reflects the impact of this
condition.
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